Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from gene editing

How far should we go with gene editing in pursuit of the ‘perfect’ human?

As the world’s top human genome editing researchers gather in London, the ethical issues posed by pioneering scientific advances will be high on their agenda

The Guardian - UK

Gene editing company aims to bring dodo ‘back to life’

Scientists at US-based firm Colossal Biosciences believe they may successfully rebuild the dodo genome in the body of a living relative

Evening Standard

Gene editing company hopes to bring dodo ‘back to life’

Company is raising further $150m to pursue research on dodo which became extinct in 17th century

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The case of the first gene-edited babies

A new documentary looks at disgraced scientist He Jiankui, who helped create the first babies with edited genes

Salon

Did He Jiankui 'Make People Better'? Documentary spurs a new look at the case of the first gene-edited babies

In the four years since an experiment by disgraced scientist He Jiankui resulted in the birth of the first babies with edited genes, numerous articles, books and international commissions have reflected on whether and how heritable genome editing – that is, modifying genes that will be passed on to the…

The Conversation

Genie out of the bottle on gene editing

No longer the stuff of science fiction, gene editing must be used in a safe and ethical way, writes Dr Hilary Sheppard.

Newsroom.co.nz

Hybrid tree wrongly sold as 'sterile' highlights potential wildings solution

A hybrid pine variety in huge demand has been labelled sterile and unable to spread without any evidence to support the claim.

Newsroom.co.nz

Read news from The Economist, FT, and more,
with one subscription

Verve Therapeutics Crushed By Clinical Hold

The FDA is taking a cautious approach to gene editing clinical trials in the United States, forcing companies to go overseas for early data generation.

The Street

After Prime Medicine, What's the Next Gene Editing IPO?

Three privately-held biotech companies could be next in line for making the jump to public markets.

The Street

IBD Stock Of The Day Vertex Pharma: Why Its 'Sandbox' Approach Is Unusual In Biotech

Vertex Pharmaceuticals is the IBD Stock Of The Day as VRTX stock climbs higher on expectations for its next act in gene editing.

Investors Business Daily

The Next Crispr Gene Editing IPO Could Be Near

Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO.

The Street

Intellia, Other CRISPR Stocks Hammered On Safety Concerns In New Gene-Editing Test

Intellia said Friday it knocked out the gene responsible for a rare and deadly swelling disorder. But CRISPR stocks sank.

Investors Business Daily

Scotland should embrace UK moves on gene-editing science, says Alister Jack

ALISTER Jack has used a visit to a farming tech centre to reiterate calls for Scotland to embrace controversial gene-editing science – despite…

The National (Scotland)

Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis

Intellia Therapeutics Inc (NASDAQ:NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced additional interim data from the Phase 1 study of NTLA-2001, in vivo genome editing candidate for transthyretin (ATTR) amyloidosis. Intellia had said that at the highest dose level (1.0mg/kg), six patients had shown a 93% mean reduction in the toxic protein. In the new data,…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact

Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.

Benzinga

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

BMO Capital Sees Over 400% Upside For This Small Gene-Editing Stock

BMO Capital Markets initiated coverage on Graphite Bio Inc (NASDAQ:GRPH), with a price target of $12 and an Outperform rating. The analyst notes that Graphite's gene editing approach involves a DNA repair mechanism that is known to be less vulnerable to errors. BMO writes that Graphite's platform is expected to be safer than existing…

The National (Scotland)

Gene-editing bill should not ‘force products on Scotland’, says minister

A BILL that would ease regulations around gene editing in the food sector should not “force products on Scotland”, a minister has said.

Get all your
news in one place.

100’s of premium titles.
One news app.

The National (Scotland)

Food experts slam BBC for 'repeating Tory lies’ on genetic edited foods

THE BBC and other media have been accused of “repeating uncritically and ad nauseam” UK Government “lies” about genetically edited foods.

The Guardian - UK

Britain is paving the way for gene-edited food – will the public stomach it?

Twenty years ago, the anti-GM movement had wide backing. Experts say the current mood on gene editing is softer

The Guardian - UK

Gene editing could increase food security, UK adviser says

Legislation introduced in House of Lords aims to help speed up development of gene-edited products

Reason

Britain Finally Relaxes GMO Rules, but Advocates Want More Deregulation

New GMO rules are a good break from the E.U., but they don't go far enough.

The Independent UK

Queen’s Speech: Gene editing of animals and plants to get green light

Bill to relax regulations part of plan to ditch EU rules after Brexit

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.